The use of Adobe Sign for creating and managing GxP eSignatures is increasingly sought after by the life science community. In our last webinar on eSignatures, 48% of attendees shared that they plan to manage regulated GxP eSignatures in Adobe Sign, and 32% already had the solution in place.

While it may be tempting to leave paper-and-ink solutions behind us and switch to a cloud-based solution, Adobe Sign customers still need to do their due diligence. The FDA’s 21 CFR Part 11 requires the validation of systems used for electronic records and signatures. Those who wish to leverage Adobe Sign must establish that the system’s functions and identity authentication settings meet the applicable regulatory requirements.

With powerful, configurable controls and protocols, it’s no wonder more teams are turning toward cloud-based eSignature solutions like Adobe Sign. Let’s uncover the advantages that Adobe makes available to you, the customer, to reduce the validation burden.